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Renal biopsy is one of the most important procedures in clinical nephrology. In most cases, a percutaneous 
ultrasound-guided renal biopsy is performed. The histological analysis of biopsy tissues is important for the 
diagnosis and prognosis assessment of renal diseases, as well as determining the treatment  strategy1. Although 
renal biopsy is an undisputed diagnostic procedure, nephrologists/urologists must consider both the benefits and 
potential complications of renal biopsy. The complications associated with percutaneous renal biopsy include 
haemorrhage, blood transfusion, and loss of real function. A previous meta-analysis has reported that renal 
biopsy is associated with a considerable rate of bleeding  complications2. Thus, the number of punctures should 
be minimised and it is important to evaluate the quality of the obtained tissues to avoid unnecessary puncture.
Gamma-glutamyl hydroxymethyl rhodamine green (gGlu-HMRG) is a recently developed activatable fluores-
cent  probe3. gGlu-HMRG is non-fluorescent but emits fluorescence upon activation by γ-glutamyltranspeptidase 
(GGT)-mediated enzymatic catalysis. As some of the cancer cells exhibit enhanced expression of GGT, gGlu-
HMRG was originally developed to detect cancers. Previously, gGlu-HMRG was used to detect resected colon 
cancer in a mouse  model4. Additionally, gGlu-HMRG could detect pancreatic cancers in biopsy specimens 
obtained from endoscopic ultrasound-guided fine-needle  aspiration5. Furthermore, gGlu-HMRG could diagnose 
Helicobacter pylori infection in the gastric biopsy  specimen6. The novel gGlu-HMRG-based imaging technique 
can be applied to evaluate various biopsy specimens other than detecting cancer. The advantage of gGlu-HMRG 
is that this probe emits fluorescence immediately after activation. Therefore, it would be a powerful tool for 
rapid evaluation of the renal biopsy specimen leading to the acquisition of sufficient number of glomeruli for 
the diagnosis of glomerulopathy.
GGT is an enzyme expressed in the plasma membrane of various organs. In clinical practice, GGT is com-
monly used as a marker for liver disease or obstruction of biliary  tract7. GGT is abundantly expressed in the kid-
ney with the cortex exhibiting higher GGT activity than the medulla or  papilla8,9. It is important to obtain renal 
biopsy tissues containing adequate glomeruli for histological assessment. As glomeruli are localised exclusively 
open
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in the renal cortex, gGlu-HMRG may aid in determining the glomerulus content in the biopsy specimen. Rapid 
evaluation of the biopsy specimen would result in reducing unnecessary puncture and accurate diagnosis. In this 
study, we investigated the feasibility of this activatable fluorescent probe for on-site evaluation of renal biopsy 
specimens.
Results
Fluorescence imaging of cell culture.  GGT is highly expressed in the proximal tubule, which is located 
in the renal  cortex8. Thus, we first investigated the fluorescence signal in the renal proximal tubule epithelial cells 
(RPTECs) after treatment with gGlu-HMRG. We also investigated the fluorescence in cortical collecting duct 
cells as the negative control. The RPTECs and collecting duct cells were treated with 10 or 50 μM gGlu-HMRG. 
The fluorescence images were obtained at 1, 3, 5, and 10 min post-gGlu-HMRG administration. The fluorescence 
signal was clearly detected in the RPTECs, whereas it could not be detected in the cortical collecting duct cells 
(Fig. 1A,B). The fluorescence signal in the RPTECs was stronger when gGlu-HMRG was applied at higher con-
centration and the intensity gradually increased immediately after the administration of gGlu-HMRG (Fig. 1).
Fluorescence  imaging of mouse kidneys.  Next, the mouse kidneys were treated with gGlu-HMRG 
ex vivo. The kidneys from C57BL6/J mice were transversely sectioned. The sectioned kidneys were rinsed with 
phosphate-buffered saline (PBS) at pH 7.4 and treated with 50 μM gGlu-HMRG. The fluorescence signal was 
detected at 1 min post-gGlu-HMRG administration. The fluorescence intensities gradually increased and pla-
teaued at 10 min (Fig. 2A,B). Further, the effect of gGlu-HMRG treatment on the morphology of the tissue was 
evaluated by immunohistochemistry. There was no marked change in the morphology of gGlu-HMRG-treated 
and negative control tissues. This suggested that gGlu-HMRG had little influence on the histological assessment 
of renal disease (Fig. 2C). In addition, we have confirmed that gGlu-HMRG had no relevant effect on immuno-
fluorescent staining or electron microscopy (Supplementary Fig. S1 online).
Fluorescence imaging of renal biopsy specimens.  The fluorescence images of renal biopsy specimens 
were obtained from 12 patients (Table 1). The fluorescence signal was detected in all examined specimens. The 
representative fluorescence images are shown in Fig. 3. The fluorescence signal was detected immediately after 
administration and the intensity increased at 3 min post-gGlu-HMRG administration. Additionally, the fluores-
Figure 1.  In vitro experiments with RPTECs and M-1 cells. Phase-contrast and fluorescence images of (A) 
RPTECs and (B) M-1 cells. gGlu-HMRG was diluted in phosphate-buffered saline and applied at concentrations 
of 10 or 50 μM. Fluorescence images were captured at 1, 3, 5, and 10 min post-gGlu-HMRG administration. 
The fluorescence signal was detected only in the RPTECs. gGlu-HMRG; γ-glutamyl hydroxymethyl rhodamine 
green, RPTEC; renal proximal tubule epithelial cell, M-1; mouse cortical collecting duct.
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cence intensity varied segmentally within the specimen, which was suggestive of the cortico-medullary junction 
(Fig. 3A). However, the cortico-medullary junction was not clearly visible under magnified lens (Fig. 3B). The 
histological examination using periodic acid-Schiff (PAS) staining revealed that the cortex exhibited strong fluo-
rescence intensity, whereas the medulla exhibited weak fluorescence intensity (Fig. 3A,C). These findings were 
further confirmed by immunohistochemical staining for GGT. The area exhibiting high fluorescence intensity, 
which is the cortex region, also exhibited high GGT expression (Fig. 3D). In contrast to the fluorescence image, 
Figure 2.  Ex vivo analysis of mouse kidneys. (A) Fluorescence images of the mouse kidney sections incubated 
with gGlu-HMRG. (B) The time-course of changes in the fluorescence intensities. The intensity gradually 
increased and plateaued at 10 min post-gGlu-HMRG administration. (C) Representative images of PAS and 
PAM staining obtained from paraffin-embedded mouse kidney sections incubated with gGlu-HMRG or PBS. 
There was no marked change in the two groups. gGlu-HMRG; γ-glutamyl hydroxymethyl rhodamine green, 
PAS; periodic acid-Schiff, PAM; periodic acid-methenamine silver, PBS; phosphate-buffered saline.
Table 1.  Patient characteristics and pathological diagnosis of renal biopsy. Data are presented as the median 
(range) or n (%).
Characteristic Value
N 12
Age (years) 64.5 (32–85)
Sex (male/female) 10/2
Pathological diagnosis of renal biopsy
Sclerosing glomerulosclerosis 3 (25.0)
Mesangial proliferative glomerulonephritis 2 (16.7)
Crescentic glomerulonephritis 2 (16.7)
Minor glomerular abnormality 2 (16.7)
Amyloidosis 1 (8.3)
Diabetic nephropathy 1 (8.3)
Interstitial nephritis 1 (8.3)
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the cortico-medullary junction was obscure under the magnified lens. Fluorescence microscopy analysis also 
revealed that the glomerulus was devoid of fluorescence (Supplementary Fig. S2 online). Further, the fluores-
cence intensity in the kidneys of 12 patients was quantified to investigate the feasibility of gGlu-HMRG as a 
probe to distinguish the cortex and medulla. There was no significant difference in the fluorescence intensity 
of cortex and medulla at 0 min. However, the cortex exhibited significantly enhanced fluorescence intensity at 
3 min (p < 0.05). The fold increase in the fluorescence intensity in the cortex was higher than that in the medulla 
(Fig. 4). These results indicated that the renal cortex and medulla could be distinguished by assessing the fluo-
rescence intensity. In fact, glomeruli were obviously distributed in the cortical area, where stronger fluorescence 
was observed (Supplementary Fig. S3 online).
Discussion
In this study, we demonstrated that gGlu-HMRG application generated fluorescence signals in the renal proximal 
tubular cells in vitro, mouse kidneys ex vivo, and human renal biopsy specimens. The cortex and medulla could 
be easily distinguished by assessing the fluorescence intensity. This novel gGlu-HMRG-based imaging technique 
can be a help for on-site assessment of biopsy specimens and is feasible for application in clinical nephrology.
Here, in vitro studies demonstrated that the fluorescence signals are detected in the renal proximal tubular 
cells but not in the collecting duct cells after treatment with gGlu-HMRG. These findings concur with those of the 
previous study that investigated the GGT activity in each tubular segment. The renal proximal tubule exhibited 
the highest GGT activity when compared to the other segments of the nephron, including glomerulus, thick 
ascending limb of Henle’s loop, distal convoluted tubule, and collecting  duct8. Previous in vitro studies have 
demonstrated the feasibility of gGlu-HMRG as a probe to detect the cancer cells derived from intra-abdominal 
 organs3–5,10. This technique has not been applied to normal kidneys or renal neoplasms. We provided a possible 
application of this fluorescence imaging to normal kidneys. Although we observed fluorescence variability in 
different nephron segments, application to renal neoplasms may require further investigation.
The fluorescence intensity was dependent on the gGlu-HMRG concentration and incubation duration. 
In vitro experiments revealed that 10 μM gGlu-HMRG required longer incubation time to detect the fluores-
cence signal than 50 μM gGlu-HMRG. A previous study applied 50 to 100 μM gGlu-HMRG on human biopsy 
 specimens5,6,10–12 and detected the fluorescence signal within 5 min post-gGlu-HMRG administration. In this 
study, ex vivo analysis of the mouse kidney revealed that the fluorescence signal was clearly detected at 3 min 
post-gGlu-HMRG administration. The fluorescence intensity gradually increased and plateaued after 10 min. 
Therefore, an incubation time of 3 min and 50 μM gGlu-HMRG was sufficient for the on-site assessment of renal 
biopsy specimen. There were no morphological changes observed in the mouse kidneys after PAS and periodic 
Figure 3.  Representative fluorescence images of the human biopsy specimen. (Ai) Fluorescence images 
captured at 0 and 3 min post-50 μM gGlu-HMRG administration. (Aii) Magnified fluorescence image of the 
cortico-medullary junction. (B) The image captured from the same specimen using a magnifying lens under 
white light. Cortico-medullary junction, which was clearly detected in the fluoserscence images, is obscure 
under magnified lens. (C) PAS staining image of the same specimen. (D) The same specimen was subjected to 
GGT immunostaining. The region with intense fluorescence intensity corresponds to the cortex and the area 
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acid-methenamine silver (PAM) staining. This indicated that the human specimens can be incubated with 50 μM 
gGlu-HMRG for 3 min without influencing the histological assessment. Actually, all human biopsy specimens 
could be pathologically diagnosed upon incubation with gGlu-HMRG. Another influencing factor may be the 
handling of the obtained specimens. A previous study using ovarian cancer model mice reported that pressed 
tumour emitted faint fluorescence when compared to the intact, rinsed, or cut  tumor11. The fluorescence in the 
rinsed mouse and human specimens could be detected in the present study.
Renal biopsy is considered when glomerular diseases are suspected. In most cases, the diagnosis or treat-
ment depends on the histological assessment of glomerulus. As glomeruli are exclusively distributed in the renal 
 cortex13, it is important to obtain the biopsy specimen containing the cortex. The biopsy specimens lacking the 
cortex might provide insufficient information. Stereomicroscope or magnifying lens are usually used for the 
on-site evaluation of the specimens. However, it is often difficult to clearly identify the cortex. The novel gGlu-
HMRG-based imaging technique described in this study can address this limitation. The renal proximal tubule 
that lies adjacent to the glomerulus is composed of the proximal convoluted tubule and proximal straight tubule, 
which are located mainly in the renal  cortex14. Therefore, the fluorescence signals can be detected in the biopsy 
specimens containing the renal cortex after treatment with gGlu-HMRG, which was demonstrated in this study. 
Additionally, the renal cortex and medulla could be easily distinguished by quantifying the fluorescence intensi-
ties. Although conventional histological staining such as PAS and PAM is the standard for histological diagnosis 
of glomerular diseases, gGlu-HMRG can be applied to the specimens before fixation and enables to assess the 
quality of the specimen leading to avoid unnecessary puncture.
This study has some limitations. The pathological aetiology or renal function that may potentially influence 
the fluorescence signal was not evaluated in this study because of the small number of the subjects and varied 
aetiologies of the kidney diseases. The green fluorescence of gGlu-HMRG potentially interfere with the immuno-
fluorescent staining for gamma globulin or immune complex, which is another important method for diagnosing 
glomerular diseases. However, any interference of gGlu-HMRG on immunofluorescent staining could not be 
observed in this study. A silicon rhodamine-based fluorescent probe, which emits red fluorescence, for detect-
ing GGT has been  developed15 and that would be an option for the concern about the color interference. There 
remains one concern that glomerulus was not stained by gGlu-HMRG, thus this fluorescent probe is not a direct 
indicator of the number of glomeruli contained in the specimen. We have demonstrated that the cortex, which 
contained a definite number of glomeruli, showed significant increase in the fluorescent intensity. In contrast, 
the part with weak fluorescence by gGlu-HMRG (i.e. medulla), did not contain any glomeruli.
In conclusion, we demonstrated that the activatable fluorescent probe, gGlu-HMRG, could be applied to renal 
biopsy specimens for distinguishing the renal cortex. Further clinical investigations are required to elucidate the 
fluorescence signal variations in various kidney diseases and diagnostic accuracy.
Methods
Activatable fluorescent probe.  The activatable fluorescent probe, gGlu-HMRG, was purchased from 
GORYO Chemical, Sapporo, Japan. gGlu-HMRG was dissolved in dimethyl sulfoxide at 1 mM and stored at 
− 20 °C before use. The gGlu-HMRG stock solution was thawed on ice and diluted in PBS to the indicated con-
centrations and used for the analyses.
Figure 4.  Fluorescence intensities in the cortex and medulla. (A) Fluorescence intensities in each 8 parts from 
12 patients at 0 and 3 min post-50 μM gGlu-HMRG administration. Each part was divided into the cortex or 
medulla according to the periodic acid-Schiff staining. Data were analysed by two-way analysis of variance 
with post hoc Sidak’s test. (B) Fold increase in the intensities after 3 min incubation with gGlu-HMRG. Data 
were analysed by unpaired t test. Bars indicate average ± standard error of mean (SEM). *P < 0.05. gGlu-HMRG; 
γ-glutamyl hydroxymethyl rhodamine green.
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In vitro imaging using the fluorescent probe.  The RPTECs were obtained from the American Type 
Culture Collection (ATCC, Rockville, Maryland, USA), while the mouse cortical collecting duct (M-1) cells 
were purchased from KAC Co., Ltd., Tokyo, Japan. The RPTECs were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM)/F12 supplemented with 10% foetal bovine serum, 1% l-glutamine, and 1% antibiotic G418. 
The M-1 cells were maintained in DMEM/F12 supplemented with 10% foetal bovine serum, 1% l-glutamine, 
and 5 μM dexamethasone. The cells were cultured in a humidified incubator at 37 °C in an atmosphere of 95% 
air and 5% carbon dioxide. Confluent cells were rinsed with PBS and incubated with gGlu-HMRG at a concen-
tration of 10 or 50 μM. The fluorescence images were obtained using a fluorescence microscope (BZ-X710; Key-
ence, Osaka, Japan) with the excitation wavelength of 450–470 nm and the emission wavelength of 500–550 nm 
along with the phase-contrast images.
Ex vivo imaging using the fluorescent probe.  Eight-week-old C57BL6/J male mice were purchased 
from CLEA Japan, Inc., Tokyo, Japan for ex vivo experiments. The mice were maintained in 12-h light–dark cycle 
and provided with water and standard laboratory diet ad libitum. The mice were anesthetised with isoflurane 
and the kidneys were harvested. The kidneys were transversely sectioned in 2 mm thickness and the sections 
were briefly rinsed with PBS. The kidney sections were treated with 50 μM gGlu-HMRG and exposed to an 
excitation wavelength of 450 nm. The fluorescence images were obtained using a commercially available digital 
camera equipped with an optical interference filter (~ 520 nm) immediately after gGlu-HMRG administration 
for 15 min. The kidney sections were then fixed with 4% paraformaldehyde and embedded in paraffin. Two sec-
tions were subjected to PAS and PAM staining. The animal experiments were performed in accordance with the 
ethical guidelines at Tottori University. The experimental protocols were approved by the ethical committee of 
the animal facility at the Tottori University (approval number: h30-Y035).
Fluorescent imaging of biopsy kidney specimens.  Patients who underwent percutaneous ultrasound-
guided renal biopsy were included in the study. This study was conducted in accordance with the Declaration of 
Helsinki and approved by the ethical committee of Tottori University hospital (approval number: 18A135). All 
study participants provided their informed consent. The indications of the renal biopsy were urinary abnormal-
ity or decline in renal function, which was suggestive of glomerular diseases as previously  described16. Renal 
biopsy was performed using a 16-gauge biopsy gun (Acecut; TSK Laboratory, Tochigi, Japan) under ultrasound-
guided puncture. The biopsy tissue was briefly rinsed with normal saline and subjected to fluorescence imaging 
analysis. The biopsy specimen was treated with 50 μM gGlu-HMRG and fluorescence images were obtained 
immediately and at 3 min post-gGlu-HMRG administration with the same setting used in the ex vivo experi-
ments. The specimens were then fixed in formalin and embedded in paraffin. The PAS-stained section was 
evaluated to assess the distribution of the cortex. For GGT immunostaining, a 4-μm thick section was subjected 
to antigen retrieval. The section was blocked with a solution containing 3% bovine serum albumin in PBS. The 
section was then incubated with the rabbit anti-GGT1 antibody (1:1,000, GeneTex, Irvine, CA, USA) overnight 
at 4 °C. Next, the section was incubated with the donkey anti-rabbit secondary antibody (1:500, Abcam, Tokyo, 
Japan). The images of PAS-stained and immunostained sections were obtained using BZ-X710 microscope (Key-
ence).
Fluorescence  intensity analyses.  For analysing the ex  vivo mouse samples and human samples, the 
fluorescence intensities in the acquired images were measured as previously  described17. Briefly, the kidney was 
outlined and the intensities were measured in each image using the ImageJ software (U.S. National Institutes of 
Health, Bethesda, Maryland, USA). To compare the fluorescence intensities in the cortex and medulla in renal 
biopsy specimens, the PAS staining images of the entire specimen were divided into 8 parts. Each part was 
evaluated by an experienced nephrologist (T.I.) and defined as cortex or medulla according to the PAS findings. 
The fluorescence intensities in each part were then measured from the corresponding fluorescence images. The 
fluorescence intensities in the cortex and medulla were comparatively analysed.
Statistical analysis.  Two-way analysis of variance test was performed to assess the differences in fluores-
cence intensities between cortex and medulla at 0 min and 3 min. If a significant difference was found, Sidak’s 
multiple comparison test was performed as post hoc analysis. The unpaired t test was used to assess the differ-
ences in the fold increase of fluorescent intensities between cortex and medulla. The difference was considered 
statistically significant when the P-value was less than 0.05. All values are expressed as mean ± standard error of 
mean (SEM). All statistical analyses were performed in GraphPad Prism (7.0. for Windows, GraphPad Software, 
San Diego, CA, USA).
Data availability
The datasets of this study are available from the corresponding author on reasonable request.
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